Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes

By sjmartinez • March 5, 2025

Mariette X, Borchmann S, Aspeslagh S, Szekanecz Z, Charles-Schoeman C, Schreiber S, Choy EH, Peyrin-Biroulet L, Schmalzing M, Tanaka Y, Ten Cate H, Westhovens R, van der Woude CJ, Ekoka Omoruyi EV, Faes M, Masior T, Van Hoek P, Watson C, Rudolph C, Stallmach A. Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes. RMD Open. 2025 Mar 4;11(1):e005033. doi: 10.1136/rmdopen-2024-005033. PMID: 40037922; PMCID: PMC11881192.

Tags: Antirheumatic Agents, Arthritis, Inflammation, Publications, Rheumatoid, Rheumatology

Assessment of Seroprevalence and Neutralizing Antibodies for Healthcare Worker Protection in a Crimean-Congo Hemorrhagic Fever Endemic Area

Pınarlık F, Karaşahin Ö, Yanık A, Akça D, Sarıkaya Rİ, Güllü D, Arslan EN, Yalçın S, Barlas T, Can FK, Alay H, Özden K, Kuşkucu[...]

Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies

Tajdini M, Tavakoli K, Jenkin SC, Keykhaei M, Hahn VS. Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies.[...]

Dental malocclusion and associated factors in pet rabbits: a cross-sectional study in Peru (2021-2022)

Masias K, Tejada A, Segura ER, Ormea V. Dental malocclusion and associated factors in pet rabbits: a cross-sectional study in Peru (2021-2022). N Z Vet[...]